The Utah Department of Health, Division of Medicaid and Health Financing (State agency), did not always comply with Federal Medicaid requirements for invoicing manufacturers for rebates for physician-administered drugs. The State agency did not invoice manufacturers for rebates associated with $6,188,000 ($4,387,000 Federal share) in physician-administered drugs. Of this amount, $5,189,000 ($3,679,000 Federal share) was for single-source drugs, and $999,000 ($709,000 Federal share) was for top-20 multiple-source drugs. Because the State agency's internal controls did not always ensure that it invoiced manufacturers to secure rebates, the State agency improperly claimed Federal reimbursement for these single-source drugs and top-20 multiple-source drugs.
UT
United States
